{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/6490a6a7bf64170011e867ff/68133906cea668298695be2a?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Exploring Sex Differences in Psoriatic Arthritis: Biomarkers and Beyond","description":"<p>How do biological sex differences shape the clinical presentation and treatment outcomes in psoriatic arthritis (PsA)? In this episode of <em>Inside GRAPPA</em>, Dr. Hanna Johnsson delves into groundbreaking research led by Steven Dang and Dr. Lihi Eder, supported by the GRAPPA Pilot Research Grant. Their study explores sex-related differences in PsA through proteomic analysis, uncovering unique biomarkers and pathways that could redefine personalized medicine for PsA patients.</p><p><br></p><h4><strong>What You'll Learn:</strong></h4><ul><li>The rationale behind investigating sex-specific differences in PsA.&nbsp;&nbsp;</li><li>Insights into how immune and inflammatory profiles differ between males and females.&nbsp;&nbsp;</li><li>Key findings from proteomic studies, including pivotal proteins and pathways like NETosis, Rho GTPase, and cytokine signaling.&nbsp;&nbsp;</li><li>The potential for sex-specific biomarkers to guide diagnosis and treatment in PsA.</li></ul><p><br></p><h4>🔗 <strong>Stay Connected with GRAPPA:</strong>&nbsp;&nbsp;</h4><ul><li>Visit the <a href=\"https://www.grappanetwork.org/\" rel=\"noopener noreferrer\" target=\"_blank\">GRAPPA Website</a> for more research updates.&nbsp;&nbsp;</li><li><a href=\"https://pod.link/1696134638\" rel=\"noopener noreferrer\" target=\"_blank\">Subscribe to <em>Inside GRAPPA</em> wherever you get your podcasts</a> to stay informed on the latest in PsA research.</li></ul>","author_name":"GRAPPA Network"}